Harvard Bioscience, Inc. (HBIO) vs Retractable Technologies, Inc. (RVP)
- Harvard Bioscience, Inc. HBIO 8.09 −2.65%
- Retractable Technologies, Inc. RVP 0.58 −1.69%
Harvard Bioscience, Inc. and Retractable Technologies, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $37.8M against $17.6M — 2.1× the size. Harvard Bioscience, Inc. grew revenue faster over the last twelve months: −1.06% against −11.2%. Retractable Technologies, Inc. has the higher net margin (−10.6% vs −11.9%) and the lower return on invested capital (−42.1% vs −0.41%). Across the 19 metrics below, Retractable Technologies, Inc. leads on 11 and Harvard Bioscience, Inc. on 8.
Valuation
Profitability
| Metric | HBIO | RVP | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 58.16% | (1.45%) | 54.29% |
| Operating margin | (0.28%) | (66.90%) | 1.07% |
| Net margin | (11.86%) | (10.62%) | (1.61%) |
| Free cash flow margin | (2.09%) | (15.07%) | 1.08% |
| Return on equity | (89.95%) | (4.84%) | (1.32%) |
| Return on assets | (13.32%) | (2.49%) | 0.00% |
| Return on invested capital | (0.41%) | (42.05%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack